Molecular Templates, Inc.

NASDAQ (USD): Molecular Templates, Inc. (MTEM)

Last Price

0.15

Today's Change

-0.203 (57.50%)

Day's Change

0.15 - 0.15

Trading Volume

1,339,999

Overview

Market Cap

705,792

Shares Outstanding

6 Million

Avg Volume

14,972,068

Avg Price (50 Days)

0.44

Avg Price (200 Days)

1.25

PE Ratio

-0.04

EPS

-3.05

Earnings Announcement

24-Dec-2024

Previous Close

0.14

Open

0.14

Day's Range

0.1028 - 0.147

Year Range

0.1028 - 4.12

Trading Volume

4,321,631

Price Change Highlight

1 Day Change

-23.43%

5 Day Change

-28.53%

1 Month Change

-71.03%

3 Month Change

-92.18%

6 Month Change

-90.07%

Ytd Change

-97.12%

1 Year Change

-97.13%

3 Year Change

-99.80%

5 Year Change

-99.95%

10 Year Change

-99.98%

Max Change

-100.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment